Elsevier’s EMBASE.com Partners With QUOSA

December 1, 2008

AMSTERDAM, December 1 /PRNewswire-FirstCall/ –

– For Effective Literature Search and Document Management Workflow

EMBASE(R), Elsevier’s biomedical and pharmaceutical abstract and indexing
database, today announced that it has partnered with QUOSA(TM) to enable
mutual customers to download and manage the full text of EMBASE.com search
results via a newly established EMBASE.com channel in QUOSA Information

QUOSA Information Manager boosts journal retrieval, search and management
efficiency for individual users through post-search automated full article
retrieval, article organization and specialized full-text searching. It has
proven an indispensable tool for extracting key information from full text
quickly and more easily, for example, kinetic parameters, microarray data,
adverse events and toxicity data. In combination with QUOSA Virtual Library,
the partnership enables expert searches on EMBASE.com to be integrated into
an easy-to-use current awareness and literature access solution for larger

Michael Rai, Director of Elsevier’s Pharmaceutical Development Group,
comments, “The partnership between EMBASE.com and QUOSA opens up new
possibilities and will no doubt help QUOSA users enhance their productivity
and boost efficiency. It will now be much easier to navigate from the results
of EMBASE.com searches to the full text, which is seen as one important step
to integrate critical information into a user’s daily workflow.”

EMBASE.com (http://www.info.embase.com) combines EMBASE and MEDLINE on
one platform, providing users with timely and comprehensive access to
pharmacological and biomedical literature. It contains records from over
7,000 journals published in more than 70 countries. Over 19 million
bibliographic records are included with more than 2,000 new records added
every working day. Users can navigate from citations to full text from the
world’s leading scientific, technical and medical (STM} publishers.

“The integration of EMBASE.com as a channel for use with the QUOSA
Information Manager and Virtual Library literature management application has
been invaluable in our development of a Medical eLibrary Services group,”
according to Amyas Huston, Senior Manager Medical Communications, Cubist
Pharmaceuticals, Inc. “The combined functionality allows our group to conduct
searches against both the EMBASE and MEDLINE bibliographic databases,
retrieve selected articles and provide a literature document repository for
copyright-compliant web-based access of publications to internal colleagues.”

Used extensively by the pharmaceutical industry, EMBASE.com retrieves
information to support such tasks as: new drug development and discovery of
new applications for existing drugs, drug safety and pharmacovigilance
procedures, legislative and regulatory compliance, clinical trial program
management, PI/Supplementary Protection Certificates and IB writing and
regulatory filing documentation such as New Drug Applications (NDAs).

“We are very pleased to have added EMBASE.com to our supported channels,
following on from our earlier support of Scopus,” says Malcolm MacKenzie,
President of QUOSA. “EMBASE.com users can now benefit from the full power of
our literature workflow solution, serving not only the information
specialist’s own needs, but also providing superior current awareness and
literature management for project teams and the wider organization.”

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier’s 7,000 employees in over 70
offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (http://www.sciencedirect.com/), MD Consult
(http://www.mdconsult.com/php/112054249-2/homepage), Scopus
(http://www.info.scopus.com/), bibliographic databases and online reference

Elsevier (http://www.elsevier.com/wps/find/homepage.cws_home) is a global
business headquartered in Amsterdam, The Netherlands and has offices
worldwide. Elsevier is part of Reed Elsevier Group plc
(http://www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and
information provider. Operating in the science and medical, legal, education
and business-to-business sectors, Reed Elsevier provides high-quality and
flexible information solutions to users, with increasing emphasis on the
Internet as a means of delivery. Reed Elsevier’s ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York
Stock Exchange).


QUOSA Inc. is a specialist software company focused on supplying superior
tools to life-science professionals for working with the scientific
literature and research related documents. With a large and rapidly growing
subscriber-base in academic and government research and medical centers and
at leading pharmaceutical and biotechnology companies, QUOSA’s applications
are used to compress time to insight across the key functions of the research
endeavour. For more information about QUOSA, please visit:

    Media Contact:
    Ann-Marie Roche

    EMBASE is a registered trademark of Elsevier BV.

SOURCE Elsevier

Source: newswire

comments powered by Disqus